AN ANALYSIS OF THE INHIBITION OF HIV-1 INFECTION BY CHEMOKINE-FC CHIMERA
AN ANALYSIS OF THE INHIBITION OF HIV-1 INFECTION BY CHEMOKINE-FC CHIMERA
批准号:
12670287
负责人:
HIESHIMA Kunio
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
趋化因子受体CCR5和CXCR4分别是嗜巨噬细胞和嗜t细胞系HTV-1病毒分离株的主要共受体。因此,这些趋化因子受体是抗hiv药物的潜在靶点。然而,体内hiv - 1复制的不良反应和抑制作用尚不清楚。为了了解在体内阻断这些趋化因子受体的作用,我们生成了对其野生型趋化因子(即met-RANTES-Fc和P2G-SDF-l-Fc)以及野生型趋化因子fc嵌合体(即RANTES-Fc和SDF-l-Fc)具有拮抗活性的趋化因子fc嵌合体。尽管P2G-SDF-l-Fc在体外对SDF-1有明显的拮抗作用,但met-RANTES-Fc对RANTES没有拮抗作用。因此,我们将重点放在SDF-l-Fc嵌合体上,发现SDF-1-Fc和P2G-SDF-l-Fc在体外都具有抑制X4病毒复制的作用。BALB/c小鼠血液循环中SDF-1、SDF-l-Fc和P2G-SDF-l-Fc的表观半衰期分别为< h、4h和9h。小鼠腹腔注射P2G-SDF-l-Fc可显著降低B220+CD43;骨髓中的前B细胞和B220^IeM4未成熟B细胞,这与先前关于CXCR4缺陷小鼠的报道一致。然而,当这些嵌合体被注射到X4病毒感染后的人- pbl - scid小鼠体内时,与对照PBS处理相比,激动性SDF-l-Fc和拮抗性P2G-SDF-1-Fc都显著增强了病毒的复制,后者更强。这些嵌合体在体内促进HIV-1生长的机制目前尚不清楚,但这些数据表明,在体内阻断CXCR4应该谨慎考虑。
英文摘要
Chemokine receptors CCR5 and CXCR4 are the major co-receptors for macrophage tropic and T-cell line tropic HTV-1 viral isolates, respectively. Therefore, these chemokine receptors are potential targets for anti-HIV drugs. However, the adverse effect as well as the inhibitory effect of HIV-l replication in vivo remains unknown. To understand the effects of blocking these chemokine receptors in vivo, we generated chemokine-Fc chimeras with antagonistic activity against their wild-type chemokines (i.e. met-RANTES-Fc and P2G-SDF-l-Fc) as well as wild-type chemokine-Fc chimeras (i.e. RANTES-Fc and SDF-l-Fc). Although significant antagonistic activity was observed for P2G-SDF-l-Fc against SDF-1 in vitro, met-RANTES-Fc had no antagonistic effect against RANTES. Therefore, we focused on SDF-l-Fc chimeras, and found that both SDF-1-Fc and P2G-SDF-l-Fc had inhibitory effect of X4 virus replication in vitro. The apparent half-lives of SDF-1, SDF-l-Fc, and P2G-SDF-l-Fc in the blood circulation of BALB/c mice were about <lh, 4h and 9h, respectively. Intraperitoneal injection of P2G-SDF-l-Fc into mice caused significant reduction of B220+CD43; pre-B cells and B220^IeM4 Immature B cells in the bone marrow, which is in agreement with the previous reports of CXCR4 deficient mice. However, when these chimeras were injected into the human-PBL-SCID mice after infection of X4 virus, there was a dramatic enhancement of virus replication by both agonistic SDF-l-Fc and antagonistic P2G-SDF-1-Fc, more strongly in the latter, in contrast to the control PBS treatment. The mechanism of promotion of HIV-1 growth in vivo by these chimeras is not known at present, but these data implicated that blocking CXCR4 in vivo should be considered carefully.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
稗島州雄, 義江 修: "ケモカインレセプタ-とHIV感染症"日本臨牀特集「HIV/AIDS研究の進歩」. 60・4(in press). (2002)
Shuo Hijima、Osamu Yoshie:“趋化因子受体和 HIV 感染”日本临床试验“HIV/AIDS 研究进展”特刊 60・4(印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nomiyama H, Hieshima K, et al.: "Human CC chemokine liver-expressed chemokine/CCL1 6 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes"International Immunology. 13・8. 1021-1029 (2001)
Nomiyama H、Hieshima K 等人:“人 CC 趋化因子肝脏表达的趋化因子/CCL1 6 是 CCR1、CCR2 和 CCR5 的功能性配体,由肝细胞组成型表达”国际免疫学 13・8(2001 年)。 )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
HIESHIMA, K AND YOSH1E, O: "CHEMOKINE RECEPTORS AND HTV-1 INFECTION"NIPPON RINSHO. 60(4), (IN PRESS). (2002)
HIESHIMA, K 和 YOSH1E, O:“趋化因子受体和 HTV-1 感染”NIPPON RINSHO。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nomiyama H, Hieshima K, et al.: "Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes"International Immunology. 13・8. 1021-1029 (2001)
Nomiyama H、Hieshima K 等人:“人 CC 趋化因子肝脏表达的趋化因子/CCL16 是 CCR1、CCR2 和 CCR5 的功能性配体,由肝细胞组成型表达”国际免疫学 13·8 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
ROLE OF TRANSCRIPTION FACTOR C-MAF IN THE HTLV-1 LATENT INFECTION
-
批准号:18590457
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2006
-
负责人:HIESHIMA Kunio
-
依托单位:
CCL28 Has a Dual Role in Mucosal Immunity as Chemokine with a Broad-Spectrum Antimicrobial Activity
-
批准号:14570289
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:2002
-
负责人:HIESHIMA Kunio
-
依托单位: